The AVANTI Study

Step Up and Be Part of Primary Hypothyroidism Research

What Is Primary Hypothyroidism?

The thyroid is a small, butterfly-shaped gland in the front of the neck that makes thyroid hormones (T4 and T3) that control the way the body uses energy. With hypothyroidism, or underactive thyroid, the thyroid gland does not produce enough thyroid hormones, which can lead to fatigue, weight gain, cold sensitivity, dry skin, and hair loss as well as neurological symptoms that can affect memory and mood.

What Is the AVANTI Study?

The purpose of the AVANTI Study is to evaluate if an investigational medicine is safe and effective in the treatment of primary hypothyroidism. The study will compare the effect of the investigational medicine on primary hypothyroidism and its safety with Synthetic Drug T4 (Levothyroxine).

You may qualify for the AVANTI Study if you:

– Are 18 – 75 years of age
– Have been diagnosed with primary hypothyroidism for at least 12 months
– Have been on continuous thyroid replacement therapy with an FDA approved dose of synthetic T4 for at least 12 months, and at    a stable dose for at least 3 months
– Have a BMI between 18 and 40
– Meet additional study criteria

If you qualify, investigational study medication(s) and care will be provided at no cost to you.

 For more information call 

(904) 730-0166 

Or sign up below, and our friendly staff will call you!